Exponent (NASDAQ:EXPO – Get Free Report) will likely be posting its quarterly earnings results after the market closes on Thursday, February 6th. Analysts expect Exponent to post earnings of $0.40 per share and revenue of $119.60 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Exponent Price Performance
Shares of NASDAQ EXPO opened at $91.79 on Tuesday. Exponent has a 1-year low of $74.30 and a 1-year high of $115.75. The company has a market capitalization of $4.66 billion, a price-to-earnings ratio of 44.34 and a beta of 0.71. The business has a 50-day moving average of $92.56 and a 200-day moving average of $101.05.
Insiders Place Their Bets
In other Exponent news, Director Paul R. Johnston sold 1,300 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total value of $123,539.00. Following the transaction, the director now owns 59,406 shares in the company, valued at $5,645,352.18. The trade was a 2.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders sold a total of 29,300 shares of company stock worth $3,002,989 in the last 90 days. 2.10% of the stock is owned by company insiders.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Growth Stocks: What They Are, What They Are Not
- How to Invest in Small Cap Stocks
- Manufacturing Stocks Investing
- These Are the Dividend Stocks Insiders Bought in January
- Industrial Products Stocks Investing
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
